MIRA INFORM REPORT

 

 

Report No. :

326948

Report Date :

12.06.2015

 

IDENTIFICATION DETAILS

 

Name :

MYLAN LABORATORIES LIMITED (w.e.f. 05.10.2011)

 

 

Formerly Known As :

MATRIX LABORATORIES LIMITTED

 

 

Registered Office :

Plot No.564/A/22 Road No.92, Jubilee Hills, Hyderabad – 500033, Telangana

Tel No. :

91-40-30496666

 

 

Country :

India

 

 

Financials (as on) :

31.03.2014

 

 

Date of Incorporation :

29.11.1984

 

 

Com. Reg. No.:

01-005146

 

 

Capital Investment / Paid-up Capital :

Rs.369.510 Million

 

 

CIN No.:

[Company Identification No.]

U24231TG1984PLC005146

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

HYDM02247A

 

 

PAN No.:

[Permanent Account No.]

AADCM3491M

 

 

Legal Form :

A Closely Held Public Limited Liability Company

 

 

Line of Business :

Manufacturer of Pharmaceutical Ingredients.

 

 

No. of Employees :

150 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

A (66)

 

RATING

STATUS

PROPOSED CREDIT LINE

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

Fairly Large

 

Maximum Credit Limit :

USD 120000000

 

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Exist

 

 

Comments :

Subject is a part of Mylan Inc, USA. It is an established company having fine track record.

 

The company has seen a better improvement in its sales volume as well as net profitability during 2014. Financial as well as liquidity position appears to be strong and healthy.

 

Further, the company successfully maintains strong research and development capabilities and low cost manufacturing base.

 

The ratings also take into consideration increasing competition in the international generics market.

 

However, trade relations are fair. Business is active. Payment terms are reported as regular and as per commitments.

 

In view of strong business profile and its established market position, the subject can be considered good for business dealings at usual trade terms and conditions.  

 

 

NOTES:

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31, 2015

 

Country Name

Previous Rating

(31.12.2014)

Current Rating

(31.03.2015)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

CRISIL

Rating

AA- (Long Term Rating)

Rating Explanation

High degree of safety and low credit risk.

Date

07.02.2015

 

 

Rating Agency Name

CRISIL

Rating

A1+ (Short Term Debt)

Rating Explanation

Very strong degree of safety and lowest credit risk.

Date

07.02.2015

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2013.

 

 

INFORMATION PARTED BY

 

Name :

Mr. Sachin

Designation

Finance Department

Contact No.:

91-40-30496666

Date :

10.06.2015

 

 

LOCATIONS

 

Registered Office :

Plot No.564/A/22 Road No.92, Jubilee Hills, Hyderabad – 500033, Andhra Pradesh, India

Tel. No.:

91-40-30496666 / 23550543

Fax No.:

91-40-27700343 / 30866699

E-Mail :

nagaraj.bodige@matrixlabsindia.com

mylan.india@mylan.in

harikrishna.gunturu@mylon.in

apisales@maylan.in (APIs)

fdfsales@mylan.in  (Formulations)

careers@mylan.in  (Careers)

Website :

http://mylanlabs.in

 

 

Factory:

Located at

 

  • Hyderabad (4 Factories)
  • Maharashtra  (2 Factories)
  • Aurangabad (1 Factory)
  • Indore (1 Factory)
  • Andhra Pradesh (2 Factories)

 

 

Branch Office 1 :

7th Floor, Tower 2B, Indiabulls Centre, 841, Senapati Bapat Marg, Elphinstone Road (West), Mumbai – 400021, Maharashtra, India

 

 

Branch Office 2 :

Nirmal, 20th Floor, Nariman Point, Mumbai – 400021, Maharashtra, India

 

 

DIRECTORS

 

Name :

Mr. Rajiv Malik

Designation :

Director

Address :

B - 6B, Gangotri Alaaknanda, New Delhi – 110019, India

Date of Birth/Age :

12.03.1961

Qualification :

Degree in Pharmaceutical Industry

Date of Appointment :

01.07.2008

DIN No.:

00120557

 

 

Name :

Mr. Rajiv Krishan Luthra

Designation :

Additional Director

Address :

3/15, Shanti Niketan, New Delhi - 110021, India

Date of Appointment :

30.03.2015

DIN No.:

00022285

 

 

Name :

Mr. Mohit Saraf

Designation :

Additional Director

Address :

Farm No 2, Kapashera Village, Farm House, Delhi - 110037, India

Date of Appointment :

30.03.2015

DIN No.:

00057284

 

 

Name :

Ms. Sarada Kalyani Bhagawati

Designation :

Whole-time Director / CEO

Address :

Hno. 1-1-380 / 38, Ashok Nagar Extension, Hyderabad - 500020, Andhra Pradesh, India

Date of Appointment :

01.11.2014

PAN No.:

ACXPB3665R

DIN No.:

02680074

 

 

Name :

Mr. Rakesh Bamzai

Designation :

Managing Director / CEO

Address :

No.79 / 12, Tuisi Sunny Brooks,, Sarjapur Road, Doddakannahalli, Bangalore Rural - 560035, Karnataka, India

Date of Appointment :

01.11.2014

PAN No.:

AANPB2957J

DIN No.:

06997113

 

 

KEY EXECUTIVES

 

Name :

Mr. Nagaraj Goud Bodige

Designation :

Secretary

Address :

H. No. 5-14-88, Indiranagar Colony II, APHB Colony, Movlali, Hyderabad - 500040, Andhra Pradesh, India

Date of Appointment :

25.07.2011

PAN No.:

AGYPB3840P

 

 

Name :

Mr. Sachin

Designation :

Finance Department

 

 

MAJOR SHAREHOLDERS

 

AS ON 24.09.2010

 

SHAREHOLDING DETAILS FILE ATTACHED

 

AS ON 24.09.2010

 

Equity Share Break up (Percentage of Total Equity)

 

Category

Percentage

Nationalized or other banks

0.01

Mutual funds

0.03

Foreign holdings [Foreign institutional investor(s), Foreign companie(s) Foreign financial institution(s), Non-resident Indian(s) or Overseas Corporate bodies or Others]

0.40

Bodies corporate

1.61

Other top fifty shareholders

0.20

Others

97.75

Total

100.00

 

 

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Pharmaceutical Ingredients.

 

 

Products :

Product Description

 

ITC code

T/E/E TAB 300/600/200 30BT PEP A/F

30049099

T/L/E TAB 300/300/600 30BT PEP A/F

30049099

Montelukast Sodium (MTM) USP

29334900

Valacyclovir HCl (VAP) MI USP

29335990

 

 

Brand Names :

Not Divulged

 

 

Agencies Held :

Not Divulged

 

 

Exports :

 

Products :

Finished Goods

Countries :

  • Japan
  • China
  • USA
  • Europe

 

 

Imports :

 

Products :

Raw Material

Countries :

  • USA
  • China
  • Japan
  • Ireland

 

 

Terms :

 

Selling :

L/C and Credit (30 / 60 / 90 Days)

 

 

Purchasing :

L/C and Credit (30 / 60 / 90 Days)

 

 

PRODUCTION STATUS – NOT AVAILABLE

 

 

GENERAL INFORMATION

 

Suppliers :

Company Name :

Not Divulged

Name of the Person :

Not Divulged

Contact No.:

Not Divulged

Since How Long Known :

Not Divulged

Maximum Limit Dealt :

Not Divulged

Experience :

Not Divulged

Remark :

Not Divulged

 

 

Customers :

End Users and OEM’s

 

Company Name :

Not Divulged

Name of the Person :

Not Divulged

Contact No.:

Not Divulged

Since How Long Known :

Not Divulged

Maximum Limit Dealt :

Not Divulged

Experience :

Not Divulged

Remark :

Not Divulged

 

 

No. of Employees :

150 (Approximately)

 

 

Bankers :

Banker Name :

The Bank of Nova Scotia

Branch :

-3-346/1, Road No.1, Banjara Hills, Hyderabad - 500034, Andhra Pradesh, India

Person Name (With Designation) :

Not Divulged

Contact Number :

Not Divulged

Name of Account Holder :

Not Divulged

Account Number :

Not Divulged

Account Since (Date/Year of Account Opening) :

Not Divulged

Average Balance Maintained :

Not Divulged

Credit Facilities Enjoyed (CC/OD/Term Loan) :

Cash /  Credit= Rs.1000.000 Million

Account Operation :

Not Divulged

Remark :

Not Divulged

 

  • DBS Bank Limited, Salarpuria Windsor, No.3, No.10, Ulsoor Road, Ward 78, Bangalore - 560042, Karnataka, India
  • The Hongkong and Shanghai Banking Corporation Limited, 6-3-1107 and 1108, Raj Bhavan Road, Somajiguda, Hyderabad - 500082, Andhra Pradesh, India
  • The Royal Bank of Scotland NV, Maker Maxity, 4 North Avenue, Level 3, BKC, Mumbai - 400051, Maharashtra, India
  • Export - Import Bank of India, Centre One; World Trade Centre, Cuffe Parade; Mumbai - 400005, Andhra Pradesh, India

 

 

Facilities :

SECURED LOANS

31.03.2014

Rs. In Million

31.03.2013

Rs. In Million

SHORT TERM BORROWINGS

 

 

Loans repayable on demand from banks

544.270

1328.860

Other loans and advances

2859.080

3135.840

 

 

 

Total

3403.350

4464.700

 

Banking Relations :

--

 

 

Auditors :

 

Name :

Deloitte Haskins and Sells

Chartered Accounts 

Address :

Gowra Grand, III Floor, 1-8-1-384- and 385, SP Road, Secunderabad – 500 003, Telangana, India 

PAN No. :

AACFD3771D

 

 

Membership :

--

 

 

Holding Company :

MP Laboratories (Mauritius) Limited

 

 

Ultimate Holding Company:

Mylan Inc., India

 

 

Subsidiary Company :

  • Matrix Laboratories (Xiamen) Limited
  • Jiangsu Matrix Pharmaceutical Chemical Limited
  • Matrix Laboratories Singapore Pte Limited
  • Matrix Pharma Group (Xiamen) Limited
  • Mylan Laboratories Inc
  • Astrix Laboratories Limited

 

 

Fellow Subsidiary Company :

  • Mylan Pharmaceuticals Inc.
  • Mylan Pharma UK
  • Mylan Pharmaceuticals ULC
  • Mylan Luxembourg 2 S.a.r.l
  • Mylan Seiyaku Limited
  • Mylan Luxembourg 8 S.a.r.l
  • Gerard Laboratories Ltd.
  • Agila Specialties Polska sp. Z.o.o
  • Alphapharm Pty. Limited
  • Farma Plus AS
  • Mylan Pharmaceuticals Private Limited
  • Agila Especialidades Farmaceutica Ltda
  • ArcanaArzneimittel GmbH
  • Mylan Pharma UK Limited
  • Agila Specialties Global Pte. Limited
  • Mylan Technologies, Inc.
  • Mylan Pharmaceuticals ULU
  • Mylan S.A.S.
  • Onco Laboratories Limited
  • Mylan New Zealand Limited
  • Agila Specialties Inc.
  • Xixia Pharmaceuticals (Pty) Limited
  • Mylan Ireland Holdings Limited
  • Mylan Ireland Limited
  • Mylan S.p.A

 


 

CAPITAL STRUCTURE

 

AS ON 31.03.2014

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

325000000

Equity Shares

Rs.2/- each

Rs.650.000 Million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

184756858

Equity Shares

Rs.2/- each

Rs.369.514 Million

 

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Million]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2014

31.03.2013

31.03.2012

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

369.510

312.680

312.680

(b) Reserves & Surplus

41421.410

24554.940

18223.520

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

41790.920

24867.620

18536.200

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

60339.510

6916.340

5218.080

(b) Deferred tax liabilities (Net)

4010.940

2018.230

1628.280

(c) Other long term liabilities

0.000

0.000

0.000

(d) long-term provisions

221.290

184.440

126.380

Total Non-current Liabilities (3)

64571.740

9119.010

6972.740

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

5399.010

10009.800

6828.490

(b) Trade payables

16111.710

11399.810

8550.780

(c) Other current liabilities

15591.660

4705.640

4724.910

(d) Short-term provisions

428.300

463.920

304.420

Total Current Liabilities (4)

37530.680

26579.170

20408.600

 

 

 

 

TOTAL

143893.340

60565.800

45917.540

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

26772.180

16954.720

13493.140

(ii) Intangible Assets

35426.620

1044.410

54.520

(iii) Capital work-in-progress

2562.500

1314.260

1098.010

(iv) Intangible assets under development

7646.000

0.000

0.000

(b) Non-current Investments

24.880

536.410

2451.210

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d)  Long-term Loan and Advances

3661.240

1765.830

898.200

(e) Other Non-current assets

0.000

0.000

0.000

Total Non-Current Assets

76093.420

21615.630

17995.080

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

1539.150

0.000

0.000

(b) Inventories

24704.120

17572.250

12967.350

(c) Trade receivables

22549.750

12692.880

10502.480

(d) Cash and cash equivalents

3183.850

2042.000

39.760

(e) Short-term loans and advances

5365.500

3111.900

1705.910

(f) Other current assets

10457.550

3531.140

2706.960

Total Current Assets

67799.920

38950.170

27922.460

 

 

 

 

TOTAL

143893.340

60565.800

45917.540

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2014

 

31.03.2013

31.03.2012

 

SALES

 

 

 

 

 

Income

69783.950

53920.770

39523.870

 

 

Other Income

2495.730

2059.810

448.900

 

 

TOTAL                                             

72279.680

55980.580

39972.770

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of materials consumed

39270.100

29044.530

20724.650

 

 

Purchases of stock-in-trade

972.540

1321.230

848.850

 

 

Changes in inventories of finished goods, work-in-progress and stock-in-trade

(3185.570)

(1559.540)

(867.610)

 

 

Employee benefit expense

4058.510

2918.400

2225.330

 

 

Other expenses

16935.600

12220.950

8876.130

 

 

Exceptional items

(2983.770)

1914.800

130.640

 

 

TOTAL                                    

55067.410

45860.370

31937.990

 

 

 

 

 

Less

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

17212.270

10120.210

8034.780

 

 

 

 

 

Less

FINANCIAL EXPENSES                                   

2484.620

630.160

575.690

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION

14727.650

9490.050

7459.090

 

 

 

 

 

Less

DEPRECIATION/ AMORTISATION                    

3461.790

964.650

779.260

 

 

 

 

 

 

PROFIT BEFORE TAX

11265.860

8525.400

6679.830

 

 

 

 

 

Less

TAX                                                                 

2816.780

3329.970

1987.400

 

 

 

 

 

 

PROFIT AFTER TAX

8449.080

5195.430

4692.430

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

Exports at F.O.B. value

55052.740

44478.270

34171.130

 

 

Other revenue

4301.790

65.800

31.380

 

TOTAL EARNINGS

59354.530

44544.070

34202.510

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Raw Materials

18136.720

12974.600

9018.10

 

 

Stores & Spares

694.650

371.050

205.210

 

 

Capital Goods

1110.590

1117.670

884.290

 

TOTAL IMPORTS

19941.960

14463.320

10107.600

 

 

 

 

 

 

Earnings Per Share (Rs.)

33.02

33.23

30.01

 

 

CURRENT MATURITIES OF LONG TERM DEBT DETAILS

 

 

Particulars

 

31.03.2014

(Rs. In Millions)

31.03.2013

(Rs. In Millions)

31.03.2012

(Rs. In Millions)

Current Maturities of Long term debt

529.360

1078.690

NA

Cash generated from operations

NA

NA

NA

 

 

 

 

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2014

31.03.2013

31.03.2012

Net Profit Margin

PAT / Sales

(%)

12.11

9.64

11.87

 

 

 

 

 

Operating Profit Margin

(PBDIT/Sales)

(%)

24.67

18.77

20.33

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets)

(%)

8.43

14.52

15.77

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.27

0.34

0.36

 

 

 

 

 

Debt Equity Ratio

(Total Liability /Networth)

 

1.58

0.72

0.65

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.81

1.47

1.37

 

 


 

FINANCIAL ANALYSIS

[all figures are in Rupees Million]

 

 

DEBT EQUITY RATIO

 

Particular

31.03.2012

31.03.2013

31.03.2014

 

Rs. In Million

Rs. In Million

Rs. In Million

Share Capital

312.680

312.680

369.510

Reserves & Surplus

18223.520

24554.940

41421.410

Net worth

18536.200

24867.620

41790.920

 

 

 

 

long-term borrowings

5218.080

6916.340

60339.510

Short term borrowings

6828.490

10009.800

5399.010

Total borrowings

12046.570

16926.140

65738.520

Debt/Equity ratio

0.650

0.681

1.573

 

 

 

YEAR-ON-YEAR GROWTH

 

 

Year on Year Growth

31.03.2012

31.03.2013

31.03.2014

 

Rs. In Million

Rs. In Million

Rs. In Million

Sales

39523.870

53920.770

69783.950

 

 

36.426

29.419

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2012

31.03.2013

31.03.2014

 

Rs. In Million

Rs. In Million

Rs. In Million

Sales

39523.870

53920.770

69783.950

Profit

4692.430

5195.430

8449.080

 

11.87%

9.64%

12.11%

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check list by info agents

Available in Report (Yes/No)

1

Year of establishment

Yes

2

Constitution of the entity -Incorporation details

Yes

3

Locality of the entity

Yes

4

Premises details

No

5

Buyer visit details

----------------

6

Contact numbers

Yes

7

Name of the person contacted

Yes

8

Designation of contact person

Yes

9

Promoter’s background

Yes

10

Date of Birth of Proprietor / Partners / Directors

Yes

11

Pan Card No. of Proprietor / Partners

yes

12

Voter Id Card No. of Proprietor / Partners

No

13

Type of business

Yes

14

Line of Business

Yes

15

Export/import details (if applicable)

Yes

16

No. of employees

Yes

17

Details of sister concerns

Yes

18

Major suppliers

No

19

Major customers

No

20

Banking Details

Yes

21

Banking facility details

No

22

Conduct of the banking account

Yes

23

Financials, if provided

Yes

24

Capital in the business

Yes

25

Last accounts filed at ROC, if applicable

Yes

26

Turnover of firm for last three years

Yes

27

Reasons for variation <> 20%

-------------------

28

Estimation for coming financial year

No

29

Profitability for last three years

Yes

30

Major shareholders, if available

Yes

31

External Agency Rating, if available

Yes

32

Litigations that the firm/promoter involved in

Yes

33

Market information

No

34

Payments terms

Yes

35

Negative Reporting by Auditors in the Annual Report

No

 

 

NOTE:

 

The Registered Office of the company has been shifted from 1-1-151/1, Sairam Towers, 4th Floor, Alexander Road, Secunderabad – 500003, Andhra Pradesh, India to the present address w.e.f. 15.03.2011

 

 

UNSECURED LOANS:

 

PARTICULARS

31.03.2014

Rs. In Million

31.03.2013

Rs. In Million

LONG TERM BORROWINGS

 

 

Fully convertible debentures others

50266.900

0.000

Term loans from others

10054.020

6896.330

Deferred payment liabilities

18.590

20.010

 

 

 

SHORT TERM BORROWINGS

 

 

Loans repayable on demand from banks

2.660

736.000

Other loans and advances

1993.000

4809.100

 

 

 

TOTAL

62335.170

12461.440

 

 

LITIGATION DETAILS:

 

 

CASE STATUS INFORMATION SYSTEM

 

COMPA 1572 / 2014

COMPASR 9043 / 2014

CASE IS:PENDING

 

PETITIONER

RESPONDENT

MR. V. RANGAN, CHENNAI & ANR

  VS

MYLAN LABORATORIES LTD, TELANGANA & ANR

PET.ADV. : HARI HARAN

RESP.ADV. : 

SUBJECT: COMPANY APPLICATION

DISTRICT:  HYDERABAD

 

FILING DATE:  22-12-2014

POSTING STAGE :  FOR ADMISSION

 

REG. DATE    :   23-12-2014

LISTING DATE :  24-12-2014

STATUS   :  ---------

 

HON'BLE JUDGE(S):

 

 

 

INDEX OF CHARGE:

 

Sr. No.

Charge ID

Date of Charge Creation/Modification

Charge amount secured

Charge Holder

Address

Service Request Number (SRN)

1

90262350

19/09/2003

120,000,000.00

IDBI BANK LTD.

MAHAVIR HOUSE, BASEERBAGH, HYDERABAD, Andhra Prad
esh, INDIA

-

2

90262253

24/02/2003

5,000,000.00

COOPERATIVE CENTRALE RAIFFEISEN - BOERENFEENBANK B
.A.

SINGAPORE BRANCH; 77; ROBINSON ROAD - 08 - 00, SIA BUILDING, SINGAPORE, Andhra Pradesh - 068896, INDIA

-

3

90262220

14/11/2002

75,000,000.00

PUNJAB NATIONAL BANK

RP ROAD, SECUNDRABAD, Andhra Pradesh, INDIA

-

4

90260738

25/11/1988

263,000.00

ANDHRA PRADESH STATE FINANCIAL CORPAORATION

CHIRAG ALI LANE, ABIDS, HYDERABAD, Andhra Pradesh
, INDIA

-

5

90260687

11/02/1988

3,635,000.00

AP STATE FINANCIAL CORPORATION

CHIRAG ALI LANE, HYDERABAD, Andhra Pradesh, INDIA

-

 

*Date of modification Charges

 

 

FIXED ASSETS:

 

·         Land

·         Buildings

·         Plant and Equipment

·         Furniture and Fixtures

·         Vehicles

·         Office Equipment

·         Electrical Equipment

·         Lab Equipment

·         Computer Hardware

·         Computer Software

·         Goodwill

 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.63.89

UK Pound

1

Rs.98.90

Euro

1

Rs.72.31

 

 

INFORMATION DETAILS

 

Information Gathered by :

PPT

 

 

Analysis Done by :

KAS

 

 

Report Prepared by :

ANK


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

8

PAID-UP CAPITAL

1~10

7

OPERATING SCALE

1~10

7

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

8

--PROFITABILITY

1~10

7

--LIQUIDITY

1~10

7

--LEVERAGE

1~10

7

--RESERVES

1~10

8

--CREDIT LINES

1~10

7

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

YES

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

66

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NB

NEW BUSINESS

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.